169 related articles for article (PubMed ID: 16550875)
21. Gastrointestinal stromal tumor.
Gupta P; Tewari M; Shukla HS
Surg Oncol; 2008 Aug; 17(2):129-38. PubMed ID: 18234489
[TBL] [Abstract][Full Text] [Related]
22. Outcome of metastatic GIST in the era before tyrosine kinase inhibitors.
Gold JS; van der Zwan SM; Gönen M; Maki RG; Singer S; Brennan MF; Antonescu CR; De Matteo RP
Ann Surg Oncol; 2007 Jan; 14(1):134-42. PubMed ID: 17080234
[TBL] [Abstract][Full Text] [Related]
23. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
Andtbacka RH; Ng CS; Scaife CL; Cormier JN; Hunt KK; Pisters PW; Pollock RE; Benjamin RS; Burgess MA; Chen LL; Trent J; Patel SR; Raymond K; Feig BW
Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676
[TBL] [Abstract][Full Text] [Related]
24. Primary omental gastrointestinal stromal tumor (GIST).
Todoroki T; Sano T; Sakurai S; Segawa A; Saitoh T; Fujikawa K; Yamada S; Hirahara N; Tsushima Y; Motojima R; Motojima T
World J Surg Oncol; 2007 Jun; 5():66. PubMed ID: 17565683
[TBL] [Abstract][Full Text] [Related]
25. [Successful treatment of huge peritoneal metastasis from duodenal gastrointestinal stromal tumor resistant for imatinib mesylate].
Sakakura C; Kumano T; Mizuta Y; Yamaoka N; Sagara Y; Hagiwara A; Otsuji E
Gan To Kagaku Ryoho; 2007 Nov; 34(12):2144-6. PubMed ID: 18219926
[TBL] [Abstract][Full Text] [Related]
26. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate.
Chirieac LR; Trent JC; Steinert DM; Choi H; Yang Y; Zhang J; Patel SR; Benjamin RS; Raymond AK
Cancer; 2006 Nov; 107(9):2237-44. PubMed ID: 16998931
[TBL] [Abstract][Full Text] [Related]
27. Recurrent GI bleeding and surgery following the initial response to imatinib therapy in GIST of the stomach.
El Hajj II; Chehal A; El Saghir NS
Dig Dis Sci; 2005 Jan; 50(1):65-9. PubMed ID: 15712639
[No Abstract] [Full Text] [Related]
28. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis.
Hassan I; You YN; Shyyan R; Dozois EJ; Smyrk TC; Okuno SH; Schleck CD; Hodge DO; Donohue JH
Ann Surg Oncol; 2008 Jan; 15(1):52-9. PubMed ID: 18000711
[TBL] [Abstract][Full Text] [Related]
29. Surgical resection of esophageal gastrointestinal stromal tumors.
Lee HJ; Park SI; Kim DK; Kim YH
Ann Thorac Surg; 2009 May; 87(5):1569-71. PubMed ID: 19379907
[TBL] [Abstract][Full Text] [Related]
30. [Gastrointestinal stromal tumors (GIST)].
Galbfach PJ; Langner EB; Czapiński-Tuzikiewicz T; Sroda A; Spychalski MI; Dziki AJ
Wiad Lek; 2007; 60(3-4):114-9. PubMed ID: 17726861
[TBL] [Abstract][Full Text] [Related]
31. [Gastrointestinal stromal tumors (GIST)--a paradigm of successful targeted therapy of solid tumors].
Belev B; Vrbanec D; Kralik M; Plestina S; Petricević B; Sirotković-Skerlev M
Acta Med Croatica; 2006 Dec; 60(5):471-5. PubMed ID: 17217104
[TBL] [Abstract][Full Text] [Related]
32. A phenomenal response to treatment by an advanced tumour.
Rahman SH; Roy A; Leahy M; Guillou PJ; Toogood GJ
Gut; 2004 Nov; 53(11):1582, 1616. PubMed ID: 15479675
[No Abstract] [Full Text] [Related]
33. Could imatinib replace surgery in esophageal gastrointestinal stromal tumor.
Al-Salam S; El-Teraifi HA; Taha MS
Saudi Med J; 2006 Aug; 27(8):1236-9. PubMed ID: 16883460
[TBL] [Abstract][Full Text] [Related]
34. [An update of the surgical indications for gastrointestinal stromal tumors].
Bonvalot S
J Chir (Paris); 2008; 145 Suppl 3():6S8-11. PubMed ID: 19060842
[TBL] [Abstract][Full Text] [Related]
35. [Strategy for patients with GIST after failure of imatinib].
Abe S; Kubota T
Gan To Kagaku Ryoho; 2009 Apr; 36(4):540-3. PubMed ID: 19381023
[TBL] [Abstract][Full Text] [Related]
36. [Imatinib in gastrointestinal stromal tumor treatment--results from University Hospital Centre Zagreb].
Vrbanec D; Petricević B; Majerović M; Stern-Padovan R; Belev B; Skegro M; Herceg D; Plestina S; Dedić-Plavetić N; Jakić-Razumović J
Lijec Vjesn; 2006; 128(5-6):161-6. PubMed ID: 16910417
[TBL] [Abstract][Full Text] [Related]
37. KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib.
Loughrey MB; Trivett M; Beshay V; Dobrovic A; Kovalenko S; Murray W; Lade S; Turner H; McArthur GA; Zalcberg J; Waring PM
Histopathology; 2006 Jul; 49(1):52-65. PubMed ID: 16842246
[TBL] [Abstract][Full Text] [Related]
38. Surgical management after neoadjuvant imatinib therapy in gastrointestinal stromal tumours (GISTs) with respect to imatinib resistance caused by secondary KIT mutations.
Haller F; Detken S; Schulten HJ; Happel N; Gunawan B; Kuhlgatz J; Füzesi L
Ann Surg Oncol; 2007 Feb; 14(2):526-32. PubMed ID: 17139461
[TBL] [Abstract][Full Text] [Related]
39. [How should patients with completely resected gastrointestinal stromal tumours (GIST) be followed up?].
Stelzner S; Antoni C; Haroske G; Jacobasch L; Erk JU; Ludwig K
Zentralbl Chir; 2005 Dec; 130(6):554-61. PubMed ID: 16382404
[TBL] [Abstract][Full Text] [Related]
40. Two cases of complete response after imatinib mesylate treatment of advanced GIST.
Papaxoinis G; Nikolaou M; Lianos E; Gaglia A; Economopoulos T; Pectasides D
Anticancer Res; 2006; 26(6C):4869-72. PubMed ID: 17214353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]